Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.
Vincent L, Gras L, Ceballos P, Finke J, Passweg J, Harel S, Rosinol L, Minnema M, Teipel R, van Doesum J, Hänel M, Lenain P, Botella-Garcia C, Koenecke C, Ducastelle S, Sanz J, Schroyens W, Zuckerman T, Monaco F, Koster L, de Wreede L, Hayden PJ, Schönland S, Yakoub-Agha I, Beksac M.
Vincent L, et al. Among authors: koenecke c.
Bone Marrow Transplant. 2022 Mar;57(3):499-501. doi: 10.1038/s41409-021-01560-y. Epub 2022 Jan 10.
Bone Marrow Transplant. 2022.
PMID: 35013536
No abstract available.